Clinical Trial Update: Oral Cyclosporine in Chronic Obstructive Pulmonary Disease [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating oral cyclosporine in chronic obstructive pulmonary disease has completed, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Michael Donahoe | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-05-09